[English] 日本語
Yorodumi- EMDB-75048: Human Excitatory Amino Acid Transporter 3 in 300 mM potassium and... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Human Excitatory Amino Acid Transporter 3 in 300 mM potassium and 0.1 mM Cmpd 3e in the intermediate outward-facing (iOFS) state | |||||||||
Map data | This is final map | |||||||||
Sample |
| |||||||||
Keywords | hEAAT3 / TRANSPORT PROTEIN | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.11 Å | |||||||||
Authors | Earsley A / Qiu B / Boudker O | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: EMBO J / Year: 2026Title: Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism. Authors: Pooneh Koochaki / Biao Qiu / Jesse A Coker / Alexander Earsley / Nancy S Wang / Todd Romigh / Christopher M Goins / Carleigh Salem / Dehui Mi / Emily Days / Joshua A Bauer / Shaun R Stauffer ...Authors: Pooneh Koochaki / Biao Qiu / Jesse A Coker / Alexander Earsley / Nancy S Wang / Todd Romigh / Christopher M Goins / Carleigh Salem / Dehui Mi / Emily Days / Joshua A Bauer / Shaun R Stauffer / Olga Boudker / Abhishek A Chakraborty / ![]() Abstract: Renal cell carcinomas (RCCs) depend on the trimeric sodium-coupled aspartate and glutamate transporter, SLC1A1/EAAT3; however, pharmacologically targeting SLC1A1 is challenging. Here we determined a ...Renal cell carcinomas (RCCs) depend on the trimeric sodium-coupled aspartate and glutamate transporter, SLC1A1/EAAT3; however, pharmacologically targeting SLC1A1 is challenging. Here we determined a cryo-EM structure of human SLC1A1 bound to compound 3e, a recently described SLC1A1-selective bicyclic imidazo[1,2 α]pyridine-3-amine (BIA) inhibitor with an unclear mechanism of action. 3e binds a membrane-embedded allosteric pocket accessible only in the apo state, when SLC1A1 is unbound to substrate and sodium, and likely prevents sodium and substrate binding. Moreover, by forming a wedge between the trimerization domain and the substrate-binding transport domain, alongside a cholesterol moiety from the lipid bilayer, 3e blocks SLC1A1's elevator-like movements that support the transport cycle. Mutations in this binding pocket abolish the 3e interaction and counteract 3e's cytotoxicity in RCC cells, confirming on-target activity and explaining SLC1A1 selectivity. The subsequent design of two new SLC1A1-selective BIA derivatives, PBJ1 and PBJ2, was directed by the SLC1A1-3e structures; both inhibited SLC1A1-dependent aspartate, glutamate, and cysteine metabolism and showed enhanced cytotoxicity. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_75048.map.gz | 96.9 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-75048-v30.xml emd-75048.xml | 17.2 KB 17.2 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_75048_fsc.xml | 9.9 KB | Display | FSC data file |
| Images | emd_75048.png | 60.5 KB | ||
| Filedesc metadata | emd-75048.cif.gz | 5.4 KB | ||
| Others | emd_75048_half_map_1.map.gz emd_75048_half_map_2.map.gz | 95.6 MB 95.6 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-75048 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-75048 | HTTPS FTP |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_75048.map.gz / Format: CCP4 / Size: 103 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | This is final map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.856 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: This is half map A
| File | emd_75048_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | This is half map A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: This is half map B
| File | emd_75048_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | This is half map B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : human excitatory amino acid transporter 3
| Entire | Name: human excitatory amino acid transporter 3 |
|---|---|
| Components |
|
-Supramolecule #1: human excitatory amino acid transporter 3
| Supramolecule | Name: human excitatory amino acid transporter 3 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: human excitatory amino acid transporter 3
| Macromolecule | Name: human excitatory amino acid transporter 3 / type: protein_or_peptide / ID: 1 Details: The first and second residues, "GP," are from the rescission protease cleavage site. This protein contains mutation N178T, N195T, C9A, C100A, C158A, N178T, N195T, C219A, C256W, K269C, and W441C. Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: GPMGKPARKG AEWKRFLKNN WVLLSTVAAV VLGITTGVLV REHSNLSTLE KFYFAFPGEI LMRMLKLIIL PL IISSMIT GVAALDSNVS GKIGLRAVVY YFATTLIAVI LGIVLVVSIK PGVTQKVGEI ARTGSTPEVS TVD AMLDLI RNMFPENLVQ AAFQQYKTKR ...String: GPMGKPARKG AEWKRFLKNN WVLLSTVAAV VLGITTGVLV REHSNLSTLE KFYFAFPGEI LMRMLKLIIL PL IISSMIT GVAALDSNVS GKIGLRAVVY YFATTLIAVI LGIVLVVSIK PGVTQKVGEI ARTGSTPEVS TVD AMLDLI RNMFPENLVQ AAFQQYKTKR EEVKPPSDPE MTMTEESFTA VMTTAISKTK TKEYKIVGMY SDGI NVLGL IVFALVFGLV IGKMGEKGQI LVDFFNALSD ATMKIVQIIM WYMPLGILFL IAGCIIEVED WEIFR KLGL YMATVLTGLA IHSIVILPLI YFIVVRKNPF RFAMGMAQAL LTALMISSSS ATLPVTFRCA EENNQV DKR ITRFVLPVGA TINMDGTALY EAVAAVFIAQ LNDLDLGIGQ IITISITATS ASIGAAGVPQ AGLVTMV IV LSAVGLPAED VTLIIAVDCL LDRFRTMVNV LGDAFGTGIV EKLSKKELEQ MDVSSEVNIV NPFALEST I LDNEDSDTKK SYVNGGFAVD KSDTISFTQT SQF |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 4 mg/mL |
|---|---|
| Buffer | pH: 7.4 Details: 20 mM Hepes-Tris pH 7.4, 300 mM KCl and 0.01% GDN, 0.1 mM Cmpd3e |
| Grid | Model: Quantifoil / Material: GOLD / Mesh: 300 |
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 53.9 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 0.8 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
United States, 1 items
Citation
Z (Sec.)
Y (Row.)
X (Col.)




































Processing
FIELD EMISSION GUN

